CytoDyn receives FDA guidance for its HIV biologics license application dose justification report Aug 16, 2021
CytoDyn’s flagship drug leronlimab included in Nature Communications’ study on HIV prevention Jun 7, 2021
CytoDyn forms supply and distribution deal with Indian firm for leronlimab as coronavirus treatment May 13, 2021
